7.2 Other Systems & High/Low-Prevalence Antigens

Other Systems & High/Low-Prevalence Antigens

Quick Answer: MNS, P1PK, Lewis, and I/i round out the blood group systems most likely to surface in day-to-day antibody identification. M and N sit on glycophorin A and are destroyed by proteolytic enzymes; S, s, and the high-prevalence U antigen sit on glycophorin B and are comparatively enzyme-resistant. Lewis and P1 antigens are soluble glycolipids adsorbed onto the red cell surface rather than intrinsic membrane proteins, so their antibodies are usually naturally occurring, IgM, and rarely clinically significant. Anti-I is linked to cold agglutinin disease and Mycoplasma pneumoniae infection, while anti-i is linked to infectious mononucleosis. Beyond named systems, the practical distinction between high-prevalence (public) and low-prevalence (private) antigens determines whether finding compatible blood or simply identifying the antibody is the harder problem.

The MNS System

M and N are antithetical antigens carried on glycophorin A, a heavily glycosylated sialoglycoprotein; S and s are carried on the homologous glycophorin B. Because M and N sit on the amino-terminal, protease-exposed portion of glycophorin A, ficin and papain treatment destroys their reactivity, a fact commonly used to differentiate anti-M or anti-N from other antibodies during enzyme panel testing. S and s antigens on glycophorin B are comparatively resistant to these enzymes, though not indestructible. The U antigen is a high-prevalence determinant that depends on glycophorin B being anchored properly in the membrane; a subset of S-s- red cells, seen almost exclusively in people of African ancestry, also lack U entirely. Anti-U is clinically significant and can be extremely difficult to support transfusion-wise because compatible U-negative units are rare. Anti-M and anti-N, by contrast, are frequently naturally occurring IgM antibodies that react best below 37°C and are usually considered clinically insignificant unless they demonstrate reactivity at body temperature in the indirect antiglobulin test, in which case they are treated as significant and antigen-negative units are selected.

The P1PK System and Lewis System

P1 is a glycolipid antigen expressed weakly and variably on red cells; anti-P1 is a common, naturally occurring, IgM antibody that reacts best at room temperature or in the cold and is not usually considered clinically significant. The related P antigen (globoside) is of interest less for routine antibody screening and more for its association with paroxysmal cold hemoglobinuria (PCH): the Donath-Landsteiner antibody is a biphasic IgG anti-P that binds red cells in the cold and fixes complement, causing hemolysis when the cells rewarm to body temperature. Lewis antigens (Lea and Leb) are not intrinsic membrane structures at all; they are glycolipids synthesized in secretory tissue, released into plasma, and passively adsorbed onto the red cell membrane, which is why Lewis phenotype tracks with secretor status (governed by the FUT2 gene) rather than with genes expressed on the red cell itself. Lewis antibodies are typically naturally occurring, IgM, and can be neutralized in vitro by adding plasma or saliva containing soluble Lewis substance — a useful confirmatory technique when Lewis specificity is suspected. Lewis antigens also fade during pregnancy as plasma lipoprotein changes reduce adsorption onto red cells, so a pregnant patient's red cells may transiently type as Le(a-b-) even though her genotype has not changed. Clinically, Lewis antibodies rarely cause hemolytic transfusion reactions or HDFN because IgM does not cross the placenta efficiently and complement fixation in vivo is limited, though they frequently cause confusing in vitro reactions such as unexpected hemolysis in tube testing.

The I/i System

I and i are related, developmentally regulated carbohydrate structures: the i antigen is a linear precursor chain that predominates on cord blood and fetal red cells, while the branched I antigen predominates on adult red cells as the i precursor is progressively converted during infancy. Anti-I is an extremely common, naturally occurring cold agglutinin in most adults but becomes clinically important when present at high titer and wide thermal amplitude, most classically following Mycoplasma pneumoniae infection, where it can cause cold agglutinin disease with intravascular or extravascular hemolysis. Anti-i is comparatively rare but is classically associated with infectious mononucleosis (Epstein-Barr virus infection), reacting preferentially with cord cells rather than adult cells.

High-Prevalence Versus Low-Prevalence Antigens

Antigens are broadly classified by how common they are in the general population, and this classification predicts the practical challenge an antibody will pose. High-prevalence (public) antigens — such as Ge (Gerbich), Yta, Kna, JMH, Coa, and Vel — are present in more than 99% of people. Antibodies to these antigens are rare to form but, once present, are extremely difficult to support transfusion-wise because virtually all donor units, and even standard reagent screening and panel cells, are antigen-positive; identification often requires molecular typing, and compatible blood may need to come from a sibling, an autologous unit, or a national rare donor registry such as the American Rare Donor Program. Low-prevalence (private) antigens — such as Wra, Kpa, Jsa, and Lua — are present in well under 10%, and often under 1%, of donors. Antibodies to these antigens are the opposite problem: they are relatively easy to support with compatible blood because most random donors are negative, but they are hard to identify because standard antibody screening cells are usually negative for the antigen as well, so the antibody may surface only as an unexplained incompatible crossmatch against a single donor unit rather than as a positive antibody screen.

Quick Reference